Abstract
As illustrated throughout this volume, the contemporary management of pituitary tumors has been the collective product of decades of multidisciplinary contribution. Innovation has been especially brisk during the past two decades in which the introduction of highly sensitive hormone assays, superior resolution imaging technology, trans-sphenoidal microsurgery, receptormediated pharmacotherapy, and focused beam radiotherapy have ushered in a promising new era in the diagnosis and therapy of pituitary tumors. Collectively, these contributions from many disciplines have rendered pituitary tumors eminently treatable, with many patients enjoying long term survival or cure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander JM, Biller BMK, Bikkai H, Zervas NT, Arnold A, Klibanski A (1990) Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 86: 336–340
Alvaro V, Touraine P, Raisman Vozarì R, Bai-Grenier F, Birrrian P, Joubert (Bression) D (1992) Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int J Cancer 50: 724–730
Alvaro V, Levy L, Deburay C, Roche A, Peillon F, Querat B, Joubert D (1993) Invasive human pituitary tumors express a point mutated alpha-protein kinase-C. J Clin Endocrinol Metab 77: 1125–1139
Anniko M, Tribukait B, Wersall J (1984) DNA ploidy and cell phase in human pituitary tumors. Cancer 53: 1708–1713
Asa SL, Ryan N, Kovacs K, Singer W Matangos PJ (1988) Immunohisto-chemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas. Arch Pathol Lab Med 112: 801–804
Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzales-Manchon C (1990) Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone, Proc Soc Exper Biol Med 193: 232–235
Asa SL, Kovacs K (1992a) Clinically nonfunctioning human pituitary adenomas. Can J Neurol Sci 19: 228–235
Asa SL, Kovacs K (1992b) Pituitary pathology in acromegaly. Endocrin Metab Clin North Am 21: 553–574
Asa SL, Cheng Z, Ranyar L, Singer W, Kovacs K, Smyth HS, Muller P (1992c) Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormone and gonadal steroids on hormone secretion and tumor cell morphology. J Clin Endocrinol Metab 74: 1128–1134
Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP (1993) Cell type-specific expression of the pituitary transcription activator Pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 77: 1275–1280
Atkin SL, Landolt AM, Jeffereys RV, Divewr M, Radcliff J, White MC (1993) Basic fibroblastic growth factor stimulated prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation. J Clin Endocrinol Metab 77: 831–837
Barkan AL (1992) Acromegaly. Trends Endocrinol Metab 3: 205–2192
Barrett JC (1991) Molecular mechanisms of hormonal carcinogenesis. In: Li JJ, Nandi S, Li SA (eds) Hormonal carcinogenesis. Springer, Berlin Heidelberg New York Tokyo, pp 159–163
Biller BMK, Alexander JM, Zervas NT, Hedley-White ET, Arnold A, Klibanski A (1992) Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing’s disease. J Clin Endocrinol Metab 75: 1303–1309
Billestrup N, Swanson LW, Vale W (1986) Growth hormone-releasing factor stimulated proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA 83: 6854–6857
Billestrup N, Mitchell RL, Vale W, Varma IM (1987) Growth hormone releasing factor induces c-fos expression in cultured primary pituitary cells. Mol Endocr 1: 300–305
Birman P, Michard M, Li Y, Peillon F, Bresion D (1987) Epidermal growth factor-binding sites, present in normal human and rat pituitaries are absent in human 18 pituitary adenomas. J Clin Endocrinol Metab 65: 275–281
Black EG, Logan A, Davis JRF, Sheppard MC (1990) Basic fibroblastic growth factor affects DNA synthesis and cell function and activates multiple signalling pathways in rat thyroid FRTL-5 and pituitary GH3 cells. J Endocrinol 127: 39–46
Bodner M, Karin (1987) A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of non-expressing cells. Cell 50: 267–275
Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K (1981) Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 304: 156–158
Burton FH, Hasel KW, Bloom FE, Sutcliff JG (1991) Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature 350: 74–77
Bystrom C, Larsson C, Blomberg C, et al (1990) Localization of the MEN1 gene to a small region within chromosome llql3 by deletion mapping tumors. Proc Natl Acad Sci USA 87: 1968–1972
Capra E, Rindi G, Pompei Spina M, Scappaticci S (1993) Chromosome abnormalities in a case of pituitary adenoma. Cancer Genet Cytogenet 68:140–142
Castrillo JL, Theill LE, Karin M (1991) Function of the homeodomain protein GHF-1 in pituitary cell proliferation. Science 253: 197–199
Cooper PR (1990) Nonoperative management of prolactin-secreting pituitary adenomas. In: Cooper PR (ed) Contemporary diagnosis and management of pituitary adenomas. American Association of Neurological Surgeons, Park Ridge, pp 83–100
Cramer W, Horning ES (1936) Experimental production of oestrin of pituitary tumors with hypopituitarism. Lancet 1: 247–249
Cryns VL, Alexander JP, Klibanski A, Arnold A (1993) The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 77: 644–646
Ezzat S, Melmed S (1990) The role of growth factors in the pituitary. J Clin Endocrinol Metab 13: 691–698
Fitzgibbons PL, Appley AJ, Turner RR, Bishop PC, Parker JW, Breeze RE, Weiss MH, Apuzzo MLJ (1988) Flow cytometric analysis of pituitary tumors: correlations of nuclear antigen p105 and DNA content with clinical behavior. Cancer 62: 1556–1560
Friend KE, Chiou YK, Laws ER Jr, Lopes MBS, Shupnik (1993) Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endocrinol Metab 77: 1281–1286
Furth J, Ueda G, Clifton KH (1973) The pathophysiology of pituitaries an d their tumors: methodological advances. In: Busch H (ed) Methods in cancer research, vol 10. Academic Press, New York, pp 201–277
Gerdes J, Lemke H, Baisch H, et al (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1470–1715
Gescher A (1992) Towards selective pharmacological modulation of protein kinase C-opportunities for the development of novel antineoplastic agents. Br J Cancer 66: 10–19
Gesundheit N, Petrick PA, Nissim M, Dahlberg PA, Doppman JL, Emerson GH, Braverman LF, Oldfield (1989) Thyrotropin-secreting pituitary adenomas. Clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med 111: 827–835
Gharib SD, Weirman MF, Shupnik MA, Chin WW (1990) Molecular biology of pituitary gonadotropins. Endocr Rev 11: 177–199
Girod C, Trouillas J, Claustrat B (1986) The human thyrotropic adenoma: pathologic diagnosis in five cases and critical review of the literature. Semin Diagn Pathol 3: 58–68
Gonsky R, Herman V, Melmed S, Fagin J (1991) Transforming DNA sequences present in human prolactin-secreting tumors. Mol Endocrinol 5: 1687–1695
Gospodarowicz D, Ferrera N, Schweigerer L, Neufeld G (1987) Structural characterisation and biological functions of fibroblastic growth factor. Endocr Rev 8: 95–111
Hamilton CRJ, Adams LC, Maloof F (1970) Hyperthyroidism due to thyrotro-pin-producing pituitary chromophobe adenoma. N Engl J Med 283: 1077–1080
Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329: 1318–1327
Herman V, Drasin NZ, Gonsky R, Melmed S (1993) Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 77: 50–55
Herman V, Fagan J, Gonsky R, Kovacs K, Melmed S (1990) J Clin Endocrinol Metab 71: 1427–1433
Hill SA, Falko JM, Wilson CB, Hunt WE (1982) Thyrotropin-producing pituitary adenomas. J Neurosurg 57: 515–519
Horvath E, Kovacs K (1991) The adenohypophysis. In: Kovacs K, Asa SL (eds) Functional endocrine pathology. Blackwell, Boston, pp 245–281
Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W (1980) Silent corticotroph adenomas of the human pituitary gland: a histologic, immunocytologic and ultrastructural study. Am J Pathol 98: 617–638
Horvath E, Kovacs K, Smyth HS, Killinger DW, Schiethauer BW, Randall R, et al (1988) A novel type of pituitary adenoma: morphological features and clinical correlations. J Clin Endocrinol Metab 66: 1111–1118
Hsu DW, Hakim F, Biller BMK, de La Monte S, Zervas NT, Klibanski A, Hedley-White ET (1993) Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78: 753–761
Hsu DW, Raskind PN, Hedley-White TE (1989) Vasoactive intestinal peptide in the human pituitary gland and adenomas. Am J Pathol 135: 329–338
Ironside IW, Royds JA, Jefferson AA, Timperley WR (1987) Immunlocalization of cytokeratins in the normal and neoplastic human pituitary gland. J Neurol Neurosurg Psychiatry 50: 57–65
Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359: 295–299
Jacoby LB, Hedley-White ET, Pulaski K, Seizinger BR, Martuza RL (1990) Clonal origin of pituitary adenomas. J Neurosurg 73: 1427–1433
Jameson JL, Klibanski, Black PM, Zervas NT, Lindell CM, Hsu DW, Ridgeway EC, Habner JF (1987) Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. J Clin Invest 80: 1472–1478
Joensuu H, Klemi PJ (1988) DNA aneurploidy in adenomas of endocrine organs. Am J Pathol 132: 145–151
Karga HJ, Alexander JM, Hedley-White ET, Klibanski A, Jameson JL (1992) Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 74: 914–919
Klibanski A, Zervas N (1991) Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 324: 822–831
Knosp E, Kitz K, Perneczky A (1989) Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25: 927–930
Kovacs K, Horvath E, Thorner MO, et al (1984) Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCuneAlbright syndrome. Virchows Arch (A) 403: 77–81
Kovacs K, Horvath E (1986) Tumors of the pituitary gland. In: Atlas of tumor pathology, Fascicle 21, 2nd Series. Armed Forces Institute of Pathology, Washington, pp 1–269
Kovacs K (1988) Pathology of growth hormone excess. Pathol Res Pract 183: 565–568
Kovacs K, Horvath E, Asa SL, Stefaneanu L, Sano T (1989) Pituitary cells producing more than one homone. Human pituitary adenomas. Trends Endocr Metab 1: 104–107
Kovacs K, Ryan N, Stefaneanu L (1987) Identification of corticotrophs in the human pituitary with mAB lu5, a novel immunocytochemical marker. Pathol Res Pract 182: 775–779
Kovacs K, Asa SL, Horvath E, Ryan N, Singer W, Killinger DW, Smyth HS, Scheithauer BW, Ebersold MJ (1990) Null cell adenomas of the pituitary: attempts to resolve their cytogenesis. In: Leschago J, Kameya T (eds) Endocrine pathology update. Field and Wood, New York, pp 17–31
Kovacs K, Stefaneanu L, Ezzat S, et al (1994) Prolactin producing pituitary adenoma in a male to female transsexual patient following protracted estrogen administration: a morphologic study. Arch Pathol Lab Med 118: 562–565
Landis C, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenyl cyclase in human pituitary tumors. Nature 340: 692–696
Landis CA, Harsh G, Lyons J, Davis RL, McCormick F, Bourne HR (1990) Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J Clin Endocrinol Metab 71: 1416–1420
Landolt AM, Schibata (1991) Growth, cell proliferation, and prognosis of pituitary adenomas. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travagline P, Spada A (eds) Pituitary adenomas: new trends in basic and clinical research. Elsevier, Amsterdam, pp 169–178
Larsson C, Skogseid B, oberg K, Nakamura Y, Nordenskjold M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85–87
LeRoith D, Clemmons D, Nissley P, Rechler MM (1992) Insulin-like growth factors in health and disease. Ann Int Med 116: 854–862
Levine AJ (1993) The tumor suppressor genes. Ann Rev Biochem 62: 623–651
Ley A, Lightman SL (1992) Growth hormone releasing hormone transcripts in human pituitary adenomas. J Clin Endocrinol Metab 74: 1474–1476
Li Y, Koga M, Kasayama S, et al (1992) Identification and characterization of high molecular weight forms of basic fibroblastic growth factor in human pituitary adenomas. J Clin Endocrinol Metab 75: 1436–1441
Lloyd RV, Jin L, Chandler WF, Horvath E, Stefaneanu L, Kovacs K (1994) Pituitary specific transcription factor messenger RNA expression in adenomatous and nontumorous human pituitary tissues. Lab Invest 69:570–575
Lloyd RV, Wilson BS, Kovacs K, Ryan N (1985) Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas. Arch Pathol Lab Med 109: 515–547
Marin F, Kovacs K, Stefaneanu L, Horvath E, Cheng Z (1992) S-100 protein immunopositivity in human nontumorous hypophyses and pituitary adenomas. Endocr Pathol 3: 28–38
Marin F, Cheng Z, Kovacs K (1993) Ubiquitin immunoreactivity in corticotrophs following glucocorticoid treatment and in pituitary adenomase. Arch Pathol Lab Med 117: 254–258
McComb DJ, Ryan N, Horvath E, Kovacs K (1983) Sublinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 107: 488–491
McCutcheon IE, Weintraub BD, Oldfield EH (1990) Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg 73: 674–683
Melmed S (1992) Etiology of pituitary acromegaly. Endocrinol Metab Clin North Am 21: 539–551
Melmed S, Braunstein GD, Change RJ, et al (1986) Pituitary tumors secreting growth hormone and prolactin. Ann Intern Med 105: 238–253
Mork SJ, Laerum OM (1980) Modal DNA content of human intracranial neoplasms studied by flow cytometry. J Neurosurg 53: 198–204
Mormede P, Baird A (1988) Estrogens, cyclic adenosine 3′,5′-monophosphate and phorbol esters modulate the prolactin response of GH3 cells. J Endocrinol 127: 39–46
Mountcastle RB, Roof BS, Mayfield RK, Mordes DB, Sagel J, Biggs PJ, Rawe SE (1989) Case report: pituitary adenocarcinoma in an acromegalic patient. Response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma. Am J Med Sci 298: 109–118
Nagashima T, Murovic JA, Hoshino T, Wilson CB, DeArmond SJ (1986) The proliferative potential of human pituitary tumors in situ. J Neurosurg 64:588–593
Nyquist P, Laws ER jr, Elliot E (1994) Novel features of tumors that secrete both growth hormone and prolactin in acromegaly. Neurosurgery 35: 179–184
Pernicone PJ, Scheithauer BW (1993) Invasive pituitary adenomas and pituitary carcinomas. In: Lloyd RV (ed) Surgical pathology of the pituitary gland. Saunders, Philadelphia, pp 121–136
Pichon MF, Bression D, Peillon F, et al (1980) Estrogen receptors in human pituitary adenomas. J Clin Endocrinol Metab 51: 897–902
Pietenpol JA, Holt JT, Stein RW, Moses HL (1990) Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of ketatinocyte proliferation. Proc Natl Acad Sci USA 87: 3758–3762
Prager D. Melmed S, Fagin J (1989) Feedback regulation of growth hormone gene expression by insulin-like growth factor 1. In: LeRoith D, Raizada MK (eds) Molecular and cellular biology of insulin-like growth factors and their receptors. Plenum, New York, pp 57–68
Prager D, Melmed S (1993) Molecular pathology of sporadic pitutiary tumors. Endocr Pathol 4: 175–177
Ramsdell IS (1991) Transforming growth factor-α and -β are are potent and effective inhibitors of GH4 pituitary tumor cell proliferation. Endcocrinology 128: 1981–1990
Reichlin S (1991) Functional aspects of endocrine neoplasms. In: Kovacs K, Asa SL (eds) Functional endocrine pathology, vol 2. Blackwell, Boston, pp 898–913
Roberts V, Meunier H, Vaughan J, Rivier J, Rivier C, Vale W, Sawchenko P (1989) Regulation and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology 124: 552–554
Rock JP, Babu VR, Drumheller T, Chason J (1993) Cytogenetic findings in pituitary adenomas: results of a pilot study. Surg Neurol 40: 224–229
Saeger W, Ludecke DK (1982) Pituitary adenomas with hyperfunction of TSH: frequency, histological classification, immunocytochemistry and ultrastructure. Virchows Arch 394: 255–267
Saint-Andre J-P, Rohmer V, Alhenc-Gelas F, Menard J, Bigorgne J-C, Corvol P (1986) Presence of renin, angiotensinogen and converting enzyme in human lactotroph cells and prolactin adenomas. J Clin Endocr Metab 63: 231–237
Scheithauer BW, Kovacs K, Randall RV (1983) The pituitary in untreated Addison’s disease: a histologic and immunocytologic study of 18 adenohypo-physes. Arch Pathol La Med 107: 484–487
Scheithauer BW (1984a) Surgical pathology of the pituitary: the adenomas. Part 1. Pathol Annu 19: 317–374
Scheithauer BW (1984b) Surgical pathology of the pituitary: the adenomas. Part 2. Pathol Annu 19: 269–329
Scheithauer BW, Kovacs K, Randall RV, Ryan N (1985) Pituitary gland in hypothyroidism. Histologic and immunocytologic study. Arch Pathol Lab Med 109: 499–504
Scheithauer BW, Kovacs K, Laws ER Jr, Randall RV (1986a) Pathology of invasive pituitary adenomas with special reference to functional classification. J Neurosurg 65: 733–744
Scheithauer BW, Horvath E, Kovacs K, Laws ER, Randall RV, Ryan N (1986b) Plurihormonal pituitary adenomas. Semin Diagn Pathol 6: 69–82
Scheithauer B W, Kovacs K, Randall RV, Ryan N (1989) Effects of estrogen on the human pituitary: a clinicopathologic study. Mayo Clin Proc 64: 1077–1084
Schonbrunn A, Krasnoff M, Westendorg JM, Tashjian AH (1980) Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferation. J Cell Biol 85: 786–797
Schulte HM, Oldfield EH, Allolio B, Katz DA, Berkman RA, Ali IU (1991) Clonal composition of pituitary adenomas in patients with Cushing’s disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab 73: 1302–1308
Schweigerer L, Neufeld G, Gospodarowicz D (1987) Basic fibroblastic growth factor as a growth inhibitor for cultured human tumor cells. J Clin Invest 80: 1516–1520
Selman WR, Laws ER, Scheithauer BW, Carpenter SM (1986) The occurrence of dual invasion in pituitary adenomas. J Neurosurg 64: 402–407
Smallridge RC (1987) Thyrotropin-secreting pituitary tumors. Endocrinol Metab Clin North Am 16: 765–792
Spada A, Arosio M, Bochicchio D, Bassoni N, Vallar L, Bassetti M, Faglia G (1990) Clinical, biochemical and morphological correlates in patients bearing growth hormone secreting with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71: 1421–1426
Stefaneanu L, Horvath E, Kovacs K (1989) Argyrophilic organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary. Mod Pathol 2: 192–199
Stefaneanu L, Kovacs K, Horvath E, Lloyd RV, Buchfelder M, Fahlbusch R, Smythe H (1994) In situ hybridization of estrogen receptor mRNA in human adenohypophysial cells and pituitary adenomas. J Clin Endocrincol Metab 78: 83–88
Sumi T, Stefaneanu L, Kovacs K, Asa SL, Rindi G (1993) Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr Pathol 4: 95–99
Thapar K, Horvath E, Kovacs K, Muller PJ (1992) Pituitary adenomas: recent advances in classification, histopathology and molecular biology. Diagn Oncol 2: 145–167
Thapar K, Kovacs K, Laws E, Muller PJ (1993a) Pituitary adenomas: current concepts in classification, histopathology, and molecular biology. Endocrinologist 3: 39–57
Thapar K, Stefaneanu L, Kovacs K, Horvath E, Asa SL (1993b) Plurihormonal pituitary tumors: beyond the one cell-one hormone theory. Endocr Pathol 4: 1–3
Thapar K, Kovacs K, Stefaneanu L, Smythe H, Laws ER Jr (1993c) Insulinlike growth factor 1 gene expression in human pituitary adenomas: an in situ hybridization study. Scientific Program 61st Annual Meeting, American Association of Neurological Surgeons, April 1993, Boston, pp 359
Theill LE, Castrillo J-L, Wu D, Karin M (1989) Dissection of the functional domains of the pituitary specific transcription factor GHF-1. Nature 342: 945–948
Thorner MO, Vance ML, Horvath E, Kovacs K (1992) The anterior pituitary. In: Wilson JD, Foster DW (eds) Williams textbook of endocrinology, 8th ed. Saunders, Philadelphia, pp 221–310
Tordjman K, Stern N, Ouaknine G, Yossiphov Y, Razon N, Nordenskjold M, Friedman E (1993) Activating mutations of the Gs alpha gene in nonfunctioning pituitary tumors. J Clin Endocrinol Metab 77: 765–769
U SH, Kelly P, Lee WH (1988) Abnormalities of human growth hormone gene and protooncogenes in some human pituitary adenomas. Mol Endocrinol 2: 85–89
Vallar L, Spada A, Giannattasio G (1987) Altered Gs and adenylate cyclase activity in human GH secreting pituitary tumors. Nature 330: 566–567
Vance ML (1990) Growth hormone releasing hormone. Clin Chem 36: 415–420
Vrontakis ME, Sano T, Kovacs K, Friesen HG (1990) Presence of glananin-like immunoreactivity in nontumorous corticotrophs and corticotroph adenomas of the human pituitary. J Clin Endocrinol Metab 70: 747–751
Weinberg RA (1991) Tumor suppressor genes. Science 254: 1138–1146
Weinstein LS, Shenkar A, Gejman P, Martino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325: 1688–1695
Wilson CB, Tyrell JB, Fitzgerald PA, Pitts L (1979) Neurosurgical aspects of Cushing’s disease and Nelson’s syndrome. In: Tindall GT, Collins WF (eds) Clinical management of pituitary disorders. Raven, New York, pp 99229–99238
Woodruff MFA, Ansell JD, Forbes GM, Gordon JC, Burton DI, Micklem HS (1982) Clonal interaction in tumours. Nature 299: 822–824
Yamashita S, Weiss M, Melmed S (1986) Insulin-like growth factor 1 regulates growth hormone secretion and messenger ribonucleic acid levels in human pituitary tumors. J Clin Endocrinol Metab 63: 730–734
Ying S-L (1988) Inhibins, activins, and follistatins. Gonadal proteins modulating the secretion of follicle-stimulating homone. Endocrin Rev 9: 267–293
Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M (1993) Rare mutations of the Gs alpha subunit in human endocrine tumors. Mutation detection by polymerase chain reaction-primer introduced restriction analysis. Cancer 72: 1286–1393
Zuber M, Tan EM, Ryoji M (1989) Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Mol Cell Biol 9: 57–66
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag/Wien
About this chapter
Cite this chapter
Thapar, K., Kovacs, K., Laws, E.R. (1995). The Classification and Molecular Biology of Pituitary Adenomas. In: Symon, L., et al. Advances and Technical Standards in Neurosurgery. Advances and Technical Standards in Neurosurgery, vol 22. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6898-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6898-1_1
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7428-9
Online ISBN: 978-3-7091-6898-1
eBook Packages: Springer Book Archive